Piercarlo Sarzi-Puttini

Summary

Publications

  1. ncbi request reprint Drug-induced lupus erythematosus
    Piercarlo Sarzi-Puttini
    Department of Rheumatology, Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, Milan 20157, Italy
    Autoimmunity 38:507-18. 2005
  2. doi request reprint Predicting response to anti-TNF treatment in rheumatoid arthritis patients
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 8:431-7. 2009
  3. ncbi request reprint Autoimmunity and anti-TNF-alpha agents
    Fabiola Atzeni
    Rheumatology Unit, Department of Rheumatology, University Hospital L Sacco, Via GB Grassi 74, 20157 Milan, Italy
    Ann N Y Acad Sci 1051:559-69. 2005
  4. doi request reprint Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmunity 41:111-5. 2008
  5. doi request reprint CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Rheumatology (Oxford) 51:2141-5. 2012
  6. ncbi request reprint Do physicians treat symptomatic osteoarthritis patients properly? Results of the AMICA experience
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Semin Arthritis Rheum 35:38-42. 2005
  7. doi request reprint Multidisciplinary approach to fibromyalgia: what is the teaching?
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, L Sacco University Hospital, Ospedale L Sacco, Via GB Grassi 74, Milan, Italy
    Best Pract Res Clin Rheumatol 25:311-9. 2011
  8. ncbi request reprint Potential target of infliximab in autoimmune and inflammatory diseases
    Fabiola Atzeni
    Rheumatology Unit, L Sacco Hospital, University of Milan, Via GB Grassi 74, 20157 Milan, Italy
    Autoimmun Rev 6:529-36. 2007
  9. doi request reprint Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases
    Fabiola Atzeni
    L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 9:845-8. 2010
  10. ncbi request reprint What is the role of rituximab in the treatment of rheumatoid arthritis?
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, 20157 Milan, Italy
    Autoimmun Rev 6:553-8. 2007

Detail Information

Publications74

  1. ncbi request reprint Drug-induced lupus erythematosus
    Piercarlo Sarzi-Puttini
    Department of Rheumatology, Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, Milan 20157, Italy
    Autoimmunity 38:507-18. 2005
    ....
  2. doi request reprint Predicting response to anti-TNF treatment in rheumatoid arthritis patients
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 8:431-7. 2009
    ..To identify the clinical factors predicting failure or a good clinical response in the cohort of RA patients entered in the Lombardy Rheumatology Network (LORHEN) registry after 3 years of treatment with anti-TNF agents...
  3. ncbi request reprint Autoimmunity and anti-TNF-alpha agents
    Fabiola Atzeni
    Rheumatology Unit, Department of Rheumatology, University Hospital L Sacco, Via GB Grassi 74, 20157 Milan, Italy
    Ann N Y Acad Sci 1051:559-69. 2005
    ..3% and in 12.9% of adalimumab-treated RA patients. Only limited data on the induction of aPL antibodies during TNF-alpha blocking treatment are available...
  4. doi request reprint Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmunity 41:111-5. 2008
    ..The aim of this study was to assess thyroid function as well as the prevalence and clinical value of anti-thyroid antibodies in patients with rheumatoid arthritis (RA)...
  5. doi request reprint CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Rheumatology (Oxford) 51:2141-5. 2012
    ..To evaluate the potential role of CC chemokine receptor 5 (CCR5)Δ32 polymorphism in the susceptibility to and clinical expression of Behçet's disease (BD) in a cohort of Italian patients...
  6. ncbi request reprint Do physicians treat symptomatic osteoarthritis patients properly? Results of the AMICA experience
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Semin Arthritis Rheum 35:38-42. 2005
    ..The study was designed to evaluate their prescription modalities to determine whether they matched the recently proposed treatment guidelines for OA (ACR 2000; EULAR 2000; APS 2002)...
  7. doi request reprint Multidisciplinary approach to fibromyalgia: what is the teaching?
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, L Sacco University Hospital, Ospedale L Sacco, Via GB Grassi 74, Milan, Italy
    Best Pract Res Clin Rheumatol 25:311-9. 2011
    ..Physical exercise and multimodal cognitive behavioural therapy are the most widely accepted and beneficial forms of non-pharmacological therapy...
  8. ncbi request reprint Potential target of infliximab in autoimmune and inflammatory diseases
    Fabiola Atzeni
    Rheumatology Unit, L Sacco Hospital, University of Milan, Via GB Grassi 74, 20157 Milan, Italy
    Autoimmun Rev 6:529-36. 2007
    ..A number of other more rare disorders also may be responsive to TNF blockade. We here review the current and prospective roles of infliximab in the treatment of autoimmune diseases and other conditions...
  9. doi request reprint Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases
    Fabiola Atzeni
    L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 9:845-8. 2010
    ..Furthermore, plasma ADMA levels could be used as a simple means of screening SRD patients at higher CV risk who need more aggressive treatment aimed at slowing or reversing the progression of atherosclerosis...
  10. ncbi request reprint What is the role of rituximab in the treatment of rheumatoid arthritis?
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, 20157 Milan, Italy
    Autoimmun Rev 6:553-8. 2007
    ....
  11. ncbi request reprint Dysfunctional syndromes and fibromyalgia: a 2012 critical digest
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Clin Exp Rheumatol 30:143-51. 2012
    ..This review will discuss the recent literature concerning the most common dysfunctional disorders: fibromyalgia syndrome, myalgic encephalomyelitis/chronic fatigue syndrome, and irritable bowel syndrome...
  12. pmc Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
    Fabiola Atzeni
    Rheumatology Unit, Department of Medicine, L Sacco University Hospital, 74 Via GB Grassi, 20157 Milano, Italy
    Arthritis Res Ther 8:R3. 2006
    ..Antinuclear and anti-dsDNA autoantibodies, but not anti-phospholipid autoantibodies, can be induced by adalimumab but to a lower extent than in studies with other anti-TNF blocking agents...
  13. doi request reprint Chronic widespread pain in the spectrum of rheumatological diseases
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Best Pract Res Clin Rheumatol 25:165-71. 2011
    ..A misdiagnosis harms the patients and the community. Rheumatologists should be able to recognise and distinguish primary and secondary FM, and need new guidelines and instruments to avoid making mistakes...
  14. doi request reprint Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-up
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmunity 41:87-91. 2008
    ..Aim of our study was to assess the prevalence and concentration of a panel of organ-specific autoantibodies in patients with RA and to evaluate their relationship with clinical manifestations and treatment efficacy...
  15. doi request reprint Anti-TNF therapy restores the hypothalamic-pituitary-adrenal axis
    Fabiola Atzeni
    Rheumatology Unit, University Hospital L Sacco, Milan, Italy
    Ann N Y Acad Sci 1193:179-81. 2010
    ..Long-term therapy with anti-TNF agents sensitizes the pituitary gland and improves adrenal androgen secretion, thus stimulating an alternative form of anti-inflammatory action...
  16. doi request reprint Neuroendocrine therapy of fibromyalgia syndrome: an update
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, University Hospital L Saccco, Milan, Italy
    Ann N Y Acad Sci 1193:91-7. 2010
    ..Studies predicting treatment response indicate that it is useful if not essential to tailor the choice of treatment components to the needs of individual patients...
  17. ncbi request reprint TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, University Hospital L Sacco, Via GB Grassi 74, 20157 Milan, Italy
    Autoimmun Rev 4:153-61. 2005
    ....
  18. doi request reprint Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 12:225-9. 2012
    ..To evaluate the risk of serious infections (SIs) in RA patients receiving anti-TNF therapy on the basis of the data included in the GISEA register...
  19. doi request reprint The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases
    Fabiola Atzeni
    L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 9:835-9. 2010
    ..The effects on the CV system depend on the drug itself, the dose and the period of exposure, and so CV risk should be evaluated before starting treatment with any drug...
  20. doi request reprint Cardiac involvement in systemic rheumatic diseases: An update
    Piercarlo Sarzi-Puttini
    L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 9:849-52. 2010
    ..As these are all associated with an unfavourable prognosis, it is essential to detect subclinical cardiac involvement in asymptomatic SAD patients, and begin adequate management and treatment early...
  21. doi request reprint Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndrome
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmunity 41:74-9. 2008
    ..To investigate the prevalence of antipolymer antibody (APA) in patients with fibromyalgia (FM) and to examine its association with FM severity symptoms...
  22. doi request reprint Psoriatic arthritis: clinical improvement and correlation with hormone axes in etanercept-treated patients
    Fabiola Atzeni
    Rheumatology Unit, University Hospital L Sacco, Milan, Italy
    Ann N Y Acad Sci 1193:176-8. 2010
    ..However, the greater increase in serum cortisol in comparison with serum 17OHP or ASD was related to clinical improvement, which indicates that the improvement was more related to the higher cortisol levels...
  23. doi request reprint Rheumatic manifestations in inflammatory bowel disease
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 13:20-3. 2014
    ....
  24. ncbi request reprint Complementary treatment in fibromyalgia: combination of somatic and abdominal acupuncture
    Cristina Iannuccelli
    Rheumatology Unit, Department of Internal Medicine, Sapienza University of Rome, Rome, Italy
    Clin Exp Rheumatol 30:112-6. 2012
    ..As a result, acupuncture could be very useful to relieve pain in a multidisciplinary setting...
  25. ncbi request reprint Environment and systemic lupus erythematosus: an overview
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, Department of Rheumatology, L Sacco University Hospital, Milan, Italy
    Autoimmunity 38:465-72. 2005
    ..A better understanding of the etiopathogenetic mechanism of SLE is required in order to clarify the multiple interactions between environmental exposures and genetic factors...
  26. ncbi request reprint Anti-cytokine antibodies for rheumatic diseases
    Fabiola Atzeni
    L Sacco University Hospital, Rheumatology Unit, Via GB Grassi 74, 20127, Milan, Italy
    Curr Opin Investig Drugs 10:1204-11. 2009
    ..This review describes the efficacy and adverse events associated with anti-cytokine treatments for autoimmune rheumatic diseases...
  27. ncbi request reprint Osteoarthritis of the spine
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Semin Arthritis Rheum 34:38-43. 2005
  28. doi request reprint Switching rheumatoid arthritis treatments: an update
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 10:397-403. 2011
    ..However, many RA patients can be successfully treated with a second TNF antagonist, especially those discontinuing the first because of secondary failure or adverse events...
  29. doi request reprint Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Expert Rev Clin Immunol 9:649-57. 2013
    ..The development of treatment-related ILD is a paradoxical adverse event, and patients should be warned about this rare but serious complication of biological or disease-modifying antirheumatic drug therapy. ..
  30. pmc Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
    Maurizio Benucci
    Rheumatology Unit, Department of Internal Medicine, Hospital di S Giovanni di Dio, Azienda Sanitaria di Firenze, Florence, Italy
    Biologics 7:69-75. 2013
    ....
  31. doi request reprint Twelve years' experience with etanercept in the treatment of rheumatoid arthritis: how it has changed clinical practice
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Expert Rev Clin Immunol 8:213-22. 2012
    ..However, this is closely related to current RA activity and therefore suggests that it is not directly related to the drug. This article considers the published data in terms of clinical practice and changes in the progression of RA...
  32. pmc Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect
    Fausto Salaffi
    Department of Rheumatology, Polytechnic University of the Marche Medical School, Via dei Colli 52, Jesi, Ancona, Italy
    Arthritis Res Ther 11:R125. 2009
    ....
  33. ncbi request reprint Osteoarthritis: an overview of the disease and its treatment strategies
    Piercarlo Sarzi-Puttini
    Division of Rheumatology, L Sacco University Hospital, Milan, Italy
    Semin Arthritis Rheum 35:1-10. 2005
    ..The disease course and patient's requirements often change over time, thus requiring a periodic review and readjustment of therapy rather than the rigid continuation of a single treatment...
  34. doi request reprint Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal
    Roberto Caporali
    Rheumatology Unit, University of Pavia, IRCCS Policlinico S Matteo Foundation, 27100 Pavia, Italy
    Autoimmun Rev 8:274-80. 2009
    ..As the first published registry of anti-TNFalpha-treated patients in Italy, Lombardy Rheumatology Network (LORHEN) is already making its contribution in this direction...
  35. ncbi request reprint Treatment strategy in fibromyalgia syndrome: where are we now?
    Piercarlo Sarzi-Puttini
    Clinical Research Scientist, Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Semin Arthritis Rheum 37:353-65. 2008
    ..The treatment of the fibromyalgia syndrome (FMS) is not standardized and often ineffective, and the course of disease progression is unpredictable...
  36. ncbi request reprint Autoantibody production in patients treated with anti-TNF-alpha
    Fabiola Atzeni
    Rheumatology Unit, University Hospital L Sacco, Via GB Grassi, 74, 20157 Milano, Italy
    Expert Rev Clin Immunol 4:275-80. 2008
    ..This has led some authors to conclude that it is necessary to add methotrexate to infliximab in order to reduce the risk of the appearance of anti-idiotype autoantibodies...
  37. ncbi request reprint Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Clin Exp Rheumatol 31:731-8. 2013
    ..The aim of this systematic review of the literature and meta-analysis of randomised controlled trials (RCTs) was to compare the efficacy of orally administered ketoprofen with that of ibuprofen and/or diclofenac...
  38. doi request reprint Long-term safety of abatacept in patients with rheumatoid arthritis
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 12:1115-7. 2013
    ..The aim of this review is to summarise the safety data collected in clinical trials and observational studies. ..
  39. doi request reprint Different effects of biological drugs in rheumatoid arthritis
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 12:575-9. 2013
    ..Finally, although these drugs improve the quality of life of RA patients, they considerably increase direct medical costs...
  40. ncbi request reprint Tumor necrosis factors blocking agents: analogies and differences
    Maurizio Benucci
    Rheumatology Unit, Department of Internal Medicine, Hospital di S Giovanni di Dio, Azienda Sanitaria di Firenze, Italy
    Acta Biomed 83:72-80. 2012
    ..Reviewing the biology of transmembrane TNF-alpha and its interaction with anti-TNF agents will contribute to understanding the bases of differential clinical efficacy of these promising treatment modalities...
  41. doi request reprint Chronic widespread pain: from peripheral to central evolution
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Best Pract Res Clin Rheumatol 25:133-9. 2011
    ..The two models (neurochemical and biopsychosocial) also affect our ability to find therapeutic answers...
  42. pmc Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis
    Fabiola Atzeni
    Rheumatology Unit, L, Sacco Hospital, University of Milan, Via G, B, Grassi 74, 20127 Milan, Italy
    Arthritis Res Ther 10:R51. 2008
    ..The purpose of this study was to investigate the prevalence of cyclic citrullinated peptide antibodies (anti-CCP) in patients with primary Sjögren syndrome (pSS) and its correlation with clinical and laboratory data...
  43. ncbi request reprint Increased neural sympathetic activation in fibromyalgia syndrome
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, 20157 Milano, Italy
    Ann N Y Acad Sci 1069:109-17. 2006
    ..This review discusses the general aspects of the altered HPA and ANS, sympathetic overactivity, and alterations in cardiovascular autonomic responses to gravitational stimuli...
  44. ncbi request reprint Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, University Hospital L Sacco, Milan, Italy
    Rheumatol Int 21:234-8. 2002
    ..The aim of this study was to evaluate the efficacy and tolerability of long-term treatment with cyclosporin A (CsA) in patients with psoriatic arthritis (PsA)...
  45. doi request reprint Resistant cases of psoriatic arthritis: how to manage them
    Fabiola Atzeni
    Rheumatology Unit, L Sacco Hospital, Milan, Italy
    J Rheumatol Suppl 83:73-5. 2009
    ..A number of clinical trials have shown that tumor necrosis factor antagonists are generally safe and efficacious in the treatment of PsA, and can inhibit the progression of radiographic damage...
  46. ncbi request reprint Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, 20157 Milan, Italy
    Autoimmun Rev 4:144-52. 2005
    ..We here review the current and prospective roles of infliximab in the treatment of autoimmune diseases and other conditions that do not currently have FDA or EMEA approval...
  47. ncbi request reprint Preclinical impairment of coronary flow reserve in patients with rheumatoid arthritis
    Fabiola Atzeni
    Rheumatology Unit, L Sacco Hospital, University of Milan, Milan, Italy
    Ann N Y Acad Sci 1108:392-7. 2007
    ..CFR is early reduced in RA patients without clinical evidence of heart disease as a result of impaired microcirculation. CFR seems a useful technique able to follow-up and to assess effects of new drugs on RA patients...
  48. pmc Primary and secondary autoimmune neutropenia
    Franco Capsoni
    Rheumatology Unit, Istituto Ortopedico Galeazzi, University of Milan, Milan, Italy
    Arthritis Res Ther 7:208-14. 2005
    ..Granulocyte colony-stimulating factor is a proven treatment in patients with AIN of all types and is now preferred to other possible therapies...
  49. doi request reprint High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register
    Florenzo Iannone
    Interdisciplinary Department of Medicine, Rheumatology Unit, Policlinico, Piazza G Cesare 11, 70124, Bari, Italy
    Clin Rheumatol 33:31-7. 2014
    ..These findings may aid clinicians to choose the best strategy to treat RA. ..
  50. doi request reprint The appropriate treatment of chronic pain
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Clin Drug Investig 32:21-33. 2012
    ..Selection of an effective, appropriate, personalized analgesic regimen for patients with chronic pain is achievable and is expected to enhance compliance, overall functioning and quality of life...
  51. ncbi request reprint New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis)
    Piercarlo Sarzi-Puttini
    Rheumatology Unit, University Hospital L Sacco, Via GB Grassi 74, 20157 Milan, Italy
    Curr Opin Rheumatol 16:287-92. 2004
    ..Purpose of this review is to summarize new clinical, pathogenetic and therapeutic insights of this disease...
  52. pmc Combined therapeutic approach: inflammatory bowel diseases and peripheral or axial arthritis
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milano, Italy
    World J Gastroenterol 15:2469-71. 2009
    ....
  53. ncbi request reprint Psychometric characteristics of the Italian version of the revised Fibromyalgia Impact Questionnaire using classical test theory and Rasch analysis
    Fausto Salaffi
    Department of Rheumatology, Universita Politecnica delle Marche, Ancona, Italy
    Clin Exp Rheumatol 31:41-9. 2013
    ....
  54. doi request reprint Conference scene: report on the second international congress on controversies in rheumatology & autoimmunity
    Fabiola Atzeni
    Rheumatology Unit, Luigi Sacco University Hospital, Via GB Grassi 74, 20127 Milano, Italy
    Immunotherapy 5:687-9. 2013
    ..The presentations covered a wide range of topics from genes to the side effects of biological agents, rare autoimmune diseases, the role of infections in autoimmunity, and bone alterations. ..
  55. ncbi request reprint Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?
    Maurizio Rizzi
    Center for Sleep and Respiratory Disorders, Rheumatology Unit, University Hospital L Sacco, Milan, Italy
    J Rheumatol 31:1193-9. 2004
    ..We evaluated the presence of CAP in patients with fibromyalgia (FM) compared to healthy controls...
  56. ncbi request reprint Introduction: osteoarthritis in the third millennium: a new era for an old disease?
    Mario Carrabba
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Semin Arthritis Rheum 34:1-2. 2005
  57. pmc Is it antiphospholipid syndrome?
    Maria Chiara Ditto
    Rheumatology Unit, L Sacco University Hospital, Via G B Grassi 74, 20157 Milano, Italy
    Int J Rheumatol 2010:932157. 2010
    ..This case not only reminds us of the diagnostic challenges of bacterial endocarditis, but also underlines the need for a critical application of antiphospholipid syndrome diagnostic criteria...
  58. doi request reprint Validation of the reflux disease questionnaire for an Italian population of patients with gastroesophageal reflux disease
    Fabio Pace
    Department of Clinical Sciences, Division of Gastroenterology, L Sacco University Hospital, Milan, Italy
    Eur J Gastroenterol Hepatol 20:187-90. 2008
    ..As an English and a German version of the RDQ exist, but not an Italian one, we aimed at translating the RDQ into Italian and evaluating its reliability for the use of Italian-speaking GERD patients...
  59. ncbi request reprint PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease
    Fabiola Atzeni
    Rheumatology Unit, Ospedale L Sacco, Milan, Italy
    Clin Exp Rheumatol 29:S38-43. 2011
    ..To investigate potential associations between the PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA (GpIIIa) gene and venous thrombosis and other clinical manifestations in Italian patients with Behçet's disease (BD)...
  60. ncbi request reprint Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others)
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Rheum Dis Clin North Am 32:413-26, viii. 2006
    ..Serum matrix Gla protein may be a marker of osteometabolic syndromes that cause hyperostosis and plays a role in Milwaukee shoulder syndrome...
  61. ncbi request reprint An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis
    Piercarlo Sarzi-Puttini
    Unità Operativa di Reumatologia, University Hospital L Sacco, Via G B Grassi 74, 20157 Milan, Italy
    Rheumatol Int 25:15-22. 2005
    ....
  62. ncbi request reprint Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy
    Rainer H Straub
    Department of Internal Medicine I, Laboratory of Neuroendocrinoimmunology, University Medical Center, Regensburg, Germany
    J Rheumatol 32:1253-8. 2005
    ..Since tumor necrosis factor (TNF) alters production of these hormones, we investigated changes of these hormones during anti-TNF antibody (anti-TNF) therapy with adalimumab in longstanding RA...
  63. pmc Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
    Franco Capsoni
    Department of Internal Medicine, Ospedale Maggiore Policlinico, IRCCS, University of Milan, Milan, Italy
    Arthritis Res Ther 7:R250-5. 2005
    ....
  64. ncbi request reprint Long-term prognosis and causes of death in systemic lupus erythematosus
    Andrea Doria
    Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy
    Am J Med 119:700-6. 2006
    ..We studied survival rate, prognostic factors, and causes of death in patients with systemic lupus erythematosus (SLE), particularly focusing on the influence of disease severity...
  65. ncbi request reprint Antigen preparation for immunological studies in systemic autoimmune diseases
    Sandra Zampieri
    Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy
    Ann N Y Acad Sci 1109:193-202. 2007
    ..In this review an overview of the different biochemical methods of antigen preparation and the specific methodological applications is given, also describing potential critical aspects and benefits of the different protocols...
  66. ncbi request reprint Physical and rehabilitative approaches in osteoarthritis
    Feliciantonio Di Domenica
    Rehabilitation Department, Istituto Ortopedico G Pini, Milano, Italy
    Semin Arthritis Rheum 34:62-9. 2005
  67. ncbi request reprint Estrogens in pregnancy and systemic lupus erythematosus
    Andrea Doria
    Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy
    Ann N Y Acad Sci 1069:247-56. 2006
    ..This occurrence could lead to a lower-than-expected increase of IL-6, accounting for the low humoral immune response and the low disease activity observed in the third trimester of pregnancy in such patients...
  68. ncbi request reprint Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory action
    Rainer H Straub
    Laboratory of Experimental Rheumatology and Neuroendocrino Immunology, Division of Rheumatology, Department of Internal Medicine I, University Hospital, 93042 Regensburg, Germany
    Arthritis Rheum 54:2039-46. 2006
  69. doi request reprint Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis
    Rainer H Straub
    Laboratory of Experimental Rheumatology and Neuroendocrino Immunology, Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany
    Arthritis Rheum 58:976-84. 2008
    ..We undertook this study to investigate the predictive value of hypothalamic-pituitary-adrenal (HPA) axis hormones for clinical improvement during anti-TNF therapy...
  70. ncbi request reprint Polymyositis-dermatomyositis and infections
    Sandra Zampieri
    University of Padova, Division of Rheumatology, Department of Clinical and Experimental Medicine, Italy
    Autoimmunity 39:191-6. 2006
    ..In this review, the increased risk of developing infections in these patients is also underlined and published data are reported...
  71. ncbi request reprint Influence of coping skills on health-related quality of life in patients with systemic lupus erythematosus
    Silvana Rinaldi
    University of Padova, Padova, Italy
    Arthritis Rheum 55:427-33. 2006
    ..To identify coping strategies used by patients with systemic lupus erythematosus (SLE), and to assess the influence of main clinical and coping variables on health-related quality of life (HRQOL)...
  72. ncbi request reprint The role of echocardiographic techniques in connective tissue diseases
    Maurizio Turiel
    Department of Cardiology, Istituto Galeazzi, University of Milan, Via Galeazzi 4, 20161 Milano, Italy
    Autoimmun Rev 4:171-7. 2005
    ....
  73. ncbi request reprint Systemic lupus erythematosus, atherosclerosis, and autoantibodies
    Sandra Zampieri
    Division of Rheumatology, University of Padova, Via Giustiniani 2, I 35128 Padua, Italy
    Ann N Y Acad Sci 1051:351-61. 2005
    ....
  74. doi request reprint Organ specific-autoantibodies: their role as markers and predictors of disease
    Piercarlo Sarzi-Puttini
    Autoimmunity 41:1-10. 2008